Chemed (NYSE:CHE) Releases Quarterly Earnings Results, Misses Expectations By $0.12 EPS

Chemed (NYSE:CHE) posted its earnings results on Tuesday. The company reported $5.64 earnings per share (EPS) for the quarter, missing the consensus estimate of $5.76 by ($0.12), Briefing.com reports. The firm had revenue of $606.18 million during the quarter, compared to analysts’ expectations of $612.22 million. Chemed had a return on equity of 27.86% and a net margin of 12.69%. The business’s revenue for the quarter was up 7.4% compared to the same quarter last year. During the same quarter in the prior year, the company earned $5.32 earnings per share. Chemed updated its FY24 guidance to $23.00-$23.15 EPS and its FY 2024 guidance to 23.000-23.150 EPS.

Chemed Price Performance

NYSE:CHE traded down $5.55 during trading hours on Friday, hitting $534.69. The company had a trading volume of 113,136 shares, compared to its average volume of 84,796. Chemed has a 52 week low of $525.36 and a 52 week high of $654.62. The company has a market capitalization of $8.05 billion, a PE ratio of 27.32, a price-to-earnings-growth ratio of 2.18 and a beta of 0.44. The stock has a 50-day moving average price of $586.09 and a 200 day moving average price of $568.84.

Insider Activity

In other news, CEO Kevin J. Mcnamara sold 2,000 shares of Chemed stock in a transaction dated Thursday, September 26th. The stock was sold at an average price of $598.81, for a total value of $1,197,620.00. Following the completion of the transaction, the chief executive officer now owns 103,735 shares of the company’s stock, valued at $62,117,555.35. The trade was a 0.00 % decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. In other Chemed news, CEO Kevin J. Mcnamara sold 2,000 shares of Chemed stock in a transaction on Thursday, September 26th. The stock was sold at an average price of $598.81, for a total value of $1,197,620.00. Following the completion of the sale, the chief executive officer now owns 103,735 shares of the company’s stock, valued at approximately $62,117,555.35. This trade represents a 0.00 % decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Also, Director George J. Walsh III sold 400 shares of the company’s stock in a transaction dated Thursday, September 26th. The shares were sold at an average price of $597.47, for a total transaction of $238,988.00. Following the transaction, the director now owns 3,046 shares in the company, valued at $1,819,893.62. This represents a 0.00 % decrease in their position. The disclosure for this sale can be found here. Insiders sold a total of 7,144 shares of company stock worth $4,141,679 in the last quarter. 3.32% of the stock is owned by company insiders.

About Chemed

Chemed Corporation provides hospice and palliative care services to patients through a network of physicians, registered nurses, home health aides, social workers, clergy, and volunteers primarily in the United States. The company operates in VITAS and Roto-Rooter segments. It offers plumbing, drain cleaning, excavation, water restoration, and other related services to residential and commercial customers through company-owned branches, independent contractors, and franchisees.